Alfa Laval wins SEK 90 million pharmaceutical order in India
Alfa Laval – a world leader in heat transfer, centrifugal separation and fluid handling – has won an order from a major pharmaceutical company in India to supply a processing line for a new insulin plant in Malaysia. The order is worth approximately SEK 90 million and delivery is scheduled for 2014.
The order includes a variety of Alfa Laval equipment for fermentation, fluid handling and tank cleaning, forming a complete processing line for insulin production.
“The pharmaceutical industry requires hygienic and safe equipment that comply with the rigorous industry standards. This order is driven by the increased living standard and confirms our position as a reliable supplier to the industry”, says Lars Renström, President and CEO of the Alfa Laval Group.
Did you know… that Alfa Laval celebrates 75 years in India, this year, and that the first office was established in Mumbai?
About Alfa Laval
Alfa Laval is a leading global provider of specialized products and engineering solutions based on its key technologies of heat transfer, separation and fluid handling.
The company’s equipment, systems and services are dedicated to assisting customers in optimizing the performance of their processes. The solutions help them to heat, cool, separate and transport products in industries that produce food and beverages, chemicals and petrochemicals, pharmaceuticals, starch, sugar and ethanol.
Alfa Laval’s products are also used in power plants, aboard ships, in the mechanical engineering industry, in the mining industry and for wastewater treatment, as well as for comfort climate and refrigeration applications.
Alfa Laval’s worldwide organization works closely with customers in nearly 100 countries to help them stay ahead in the global arena.
Alfa Laval is listed on Nasdaq OMX, and, in 2011, posted annual sales of about SEK 28.6 billion (approx. 3.2 billion Euros). The company has today about 16 000 employees.
For more information please contact:
Senior Vice President, Communications
Tel: + 46 46 36 72 31
Mobile: +46 709 33 72 31
Investor Relations Manager
Tel: +46 46 36 74 82
Mobile: +46 709 78 74 82